Sera Prognostics (SERA) Change in Receivables (2020 - 2026)
Sera Prognostics (SERA) reported Change in Receivables of -$1000.0 for Q1 2026, up 88.89% on a YoY basis from -$529.41 in Q1 2025, and up 66.67% quarter-over-quarter from -$3000.0 in Q4 2025.
Sera Prognostics (SERA) Change in Receivables (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Change in Receivables for 7 years, with the latest figure at -$1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 88.89% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2026 stood at -$14000.0 (down 240.0% YoY), and the FY2025 full-year result was -$22000.0, up 99.81% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1000.0, up from -$3000.0 in the prior quarter.
- The five-year high for Change in Receivables was $11.3 million in Q4 2023, with the low at -$11.3 million in Q1 2024.
- Historically, Change in Receivables has averaged -$240000.0 across 5 years, with a median of -$8000.0 in 2025.
- Annual changes were most pronounced in 2024 — Change in Receivables tumbled 199.12% — and 2025, when it jumped 99.97%.
- Sera Prognostics' Change in Receivables stood at $6.0 million in 2022, then soared by 88.5% to $11.3 million in 2023, then plunged by 199.12% to -$11.2 million in 2024, then jumped by 99.97% to -$3000.0 in 2025, then soared by 66.67% to -$1000.0 in 2026.
- The last three Change in Receivables figures came in at -$1000.0 (Q1 2026), -$3000.0 (Q4 2025), and -$2000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -11.21 Mn |
| Dec 31, 2024 | -11.21 Mn |
| Sep 30, 2024 | -22,000.00 |
| Sep 30, 2024 | -22,000.00 |
| Jun 30, 2024 | 11.25 Mn |
| Jun 30, 2024 | 11.25 Mn |
| Mar 31, 2024 | -11.31 Mn |
| Mar 31, 2024 | -11.31 Mn |
| Dec 31, 2023 | 11.31 Mn |
| Dec 31, 2023 | 11.31 Mn |